Christopher Butler

A trial like ALIC 4 E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?

H. Goossens, M. D. Jong, P. Beutels, 2018 .

Adaptive platform trials: definition, design, conduct and reporting considerations

Herman Goossens, Donald A. Berry, Lorenzo Trippa, 2019, Nature Reviews Drug Discovery.

Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases

H. Goossens, M. Koopmans, P. Horby, 2022, Clinical Microbiology and Infection.

Molnupiravir Plus Usual Care Versus Usual Care Alone as Early Treatment for Adults with COVID-19 at Increased Risk of Adverse Outcomes (PANORAMIC): Preliminary Analysis from the United Kingdom Randomised, Controlled Open-Label, Platform Adaptive Trial

E. Hadley, K. Hood, B. Jani, 2022, SSRN Electronic Journal.

Associations with Post-Consultation Health-Status in Primary Care Managed Acute Exacerbation of COPD

K. Hood, D. Gillespie, G. Naik, 2022, International journal of chronic obstructive pulmonary disease.

Patients’ and clinicians’ perspectives on the primary care consultations for acute respiratory infections during the first wave of the COVID-19 pandemic: an eight-country qualitative study in Europe

H. Goossens, J. Kinsman, C. Lionis, 2022, BJGP open.

Performance and ease of use of a molecular point-of-care test for influenza A/B and RSV in patients presenting to primary care

H. Goossens, C. Butler, V. Matheeussen, 2020, European Journal of Clinical Microbiology and Infectious Diseases.

Determining the clinical and cost-effectiveness of nasal sprays and a physical activity and stress management intervention to reduce respiratory tract infections in primary care: A protocol for the ‘Immune Defence’ randomised controlled trial

J. Raftery, B. Stuart, B. Ainsworth, 2023, PloS one.

Adherence-adjusted estimates of bene fi ts and harms from treatment with amoxicillin for LRTI: secondary analysis of a 12-country randomised placebo-controlled trial using randomisation-based ef fi cacy estimators

K. Hood, B. Stuart, M. Mullee, 2023 .